Drug Repurposing for the Treatment of Childhood Leukemia

Treatment-related toxicities from conventional chemotherapy can cause suffering in many patients with childhood leukemia. The search continues for medications that are effective while producing fewer adverse effects. Pediatric hematologist/oncologist, Seth Corey, MD, MPH, explains his latest study repurposing the antimalarial drug, mefloquine.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy